Breaking news

Dec 13, 2004

Expanding its reviews of products, such as cars and appliances, Consumer Reports will compare the effectiveness and costs of a few types of widely used prescription drugs. Beginning Dec. 9, the free service was made available on the Consumer Reports Best Buy Drugs Web site at www.crbestbuydrugs.org.

Treatment For Rare Immunodeficiency Disease Gets FDA Approval

March 27th 2023

Mental Health and CBD: What's the Latest Info

October 27th 2022

Promoting Health Equity and Achieving Pharmacoequity to Ensure Medication Access for All

March 27th 2023

What CBD Brings to the Table for Dermatologic Concerns

October 11th 2022

Vaccines, Variants, and More: COVID-19 Year in Review

March 26th 2023

Pharmacogenetic Testing, Therapeutic Drug Monitoring Feasible to Monitor Sertraline Concentrations in Residential Treatment Setting

March 25th 2023

Treatment For Rare Immunodeficiency Disease Gets FDA Approval

March 27th 2023

Mental Health and CBD: What's the Latest Info

October 27th 2022

Promoting Health Equity and Achieving Pharmacoequity to Ensure Medication Access for All

March 27th 2023

What CBD Brings to the Table for Dermatologic Concerns

October 11th 2022

Vaccines, Variants, and More: COVID-19 Year in Review

March 26th 2023

Pharmacogenetic Testing, Therapeutic Drug Monitoring Feasible to Monitor Sertraline Concentrations in Residential Treatment Setting

March 25th 2023

Treatment For Rare Immunodeficiency Disease Gets FDA Approval

March 27th 2023

Mental Health and CBD: What's the Latest Info

October 27th 2022

Promoting Health Equity and Achieving Pharmacoequity to Ensure Medication Access for All

March 27th 2023

What CBD Brings to the Table for Dermatologic Concerns

October 11th 2022

Vaccines, Variants, and More: COVID-19 Year in Review

March 26th 2023

Pharmacogenetic Testing, Therapeutic Drug Monitoring Feasible to Monitor Sertraline Concentrations in Residential Treatment Setting

March 25th 2023

Related Content

Treatment For Rare Immunodeficiency Disease Gets FDA Approval

March 27th 2023

Article

The drug Leniolisib, now with the brand name Joenja, treats APDA, a genetic disorder that impairs the immune system. Its annual list price will be $547,500.

Mental Health and CBD: What's the Latest Info

October 27th 2022

Podcast

Drug Topics® is joined by Dr. Alex Capano, Chief Science Officer at Ananda Professional to discuss what CBD is used for mental health, where research should go next, and how to ensure that patients are getting effective CBD products.

paper dolls representing population diversity | Image Credit: © New Africa - adobe.stock.com

Promoting Health Equity and Achieving Pharmacoequity to Ensure Medication Access for All

March 27th 2023

Article

Speakers at the 2023 virtual Value-Based Insurance Design Summit discussed government programs and company initiatives to advance health equity, as well as the role of research and advocacy to achieve pharmacoequity.